Yes, trazodone is a psychotropic medication. It belongs to a class called serotonin modulators, meaning it works by altering serotonin activity in the brain to affect mood, sleep, and mental balance. It is FDA-approved for treating depression, though in practice it is prescribed just as often, if not more, for sleep problems.
What “Psychotropic” Actually Means
A psychotropic medication is any drug that crosses into the brain and changes how it functions, affecting mood, perception, behavior, or cognition. This is a broad category that includes antidepressants, antipsychotics, anti-anxiety medications, stimulants, and mood stabilizers. Trazodone fits squarely in this group because it directly alters serotonin signaling in the central nervous system. It is classified as an antidepressant, specifically a serotonin modulator, and is chemically unrelated to older antidepressant classes like tricyclics or MAO inhibitors.
One point of confusion: psychotropic does not mean “controlled substance.” Trazodone is not a controlled substance under DEA scheduling. You don’t need a special prescription for it the way you would for a benzodiazepine or a stimulant. It does require a standard prescription, but pharmacies and insurers treat it like any other non-controlled medication.
How Trazodone Works in the Brain
Trazodone increases serotonin activity through two complementary mechanisms. First, it blocks the reuptake of serotonin, meaning it prevents nerve cells from reabsorbing serotonin after it’s released, leaving more of it available in the gaps between neurons. Its reuptake-blocking ability is weaker than that of SSRIs like fluoxetine or citalopram, but this is partially offset by its second mechanism: it blocks specific serotonin receptors (5-HT2A and 5-HT2C) that would otherwise dampen serotonin’s mood-lifting effects.
This dual action is why trazodone is sometimes called a SARI (serotonin antagonist and reuptake inhibitor). The receptor-blocking property also appears to support norepinephrine activity in the brain, which may add to its antidepressant effect. Additionally, trazodone blocks certain adrenaline receptors, which contributes to its sedating quality and can cause drops in blood pressure when standing up.
FDA-Approved Use: Depression
Trazodone’s only FDA-approved indication is major depression. The typical starting dose is 150 mg per day, taken in divided doses for the immediate-release tablet or as a single dose for the extended-release form. Doses can be adjusted up to 400 mg per day for immediate-release or 375 mg per day for extended-release, depending on response.
The American Psychiatric Association recognizes trazodone as an effective antidepressant compared to placebo. However, the APA also notes that in modern practice, trazodone is “much more likely to be used in lower doses as a sedative-hypnotic than as an antidepressant.” This shift happened because newer antidepressants like SSRIs tend to cause less sedation during the day, making them a more practical first-line choice for many patients.
Off-Label Use for Insomnia
Trazodone’s strong sedating effect, which is technically a side effect at antidepressant doses, has made it one of the most commonly prescribed sleep aids in the United States. A study of 5.8 million patients with insomnia found that 17.7% were prescribed trazodone. When used for sleep, doses are typically much lower than those used for depression, often in the range of 25 to 100 mg at bedtime.
This use is entirely off-label. Trazodone has never received FDA approval for treating insomnia, and the APA notes that “few data support its use for this indication” despite its widespread prescribing. That said, many clinicians prefer it over traditional sleep medications because it carries no risk of physical dependence and is not a controlled substance.
Common Side Effects
Sedation is the most frequently reported side effect and the most predictable one. In clinical trials of the extended-release formulation, the side effects reported by at least 5% of patients included headache, drowsiness, dry mouth, dizziness, nausea, fatigue, diarrhea, constipation, back pain, and blurred vision. Overall, about 62% of participants in early-phase studies reported at least one side effect, though only 1.6% experienced one rated as severe.
Trazodone produces more sedation than most other modern antidepressants. This can be useful when insomnia is part of the picture, but it can also cause next-day grogginess, especially at higher doses.
Serious Risks to Know About
Trazodone carries the same boxed warning that applies to all antidepressants: an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults during the first weeks of treatment. This warning does not mean the medication causes suicidal behavior in most people, but it does mean that close monitoring matters early on.
A rare but serious risk specific to trazodone is priapism, a prolonged and painful erection unrelated to sexual arousal. This occurs in a small number of men and can require emergency medical treatment, including surgery if not addressed quickly. The APA recommends that men prescribed trazodone be warned about this possibility.
Cardiovascular effects are another concern, particularly for older adults. Trazodone can cause orthostatic hypotension, a sudden drop in blood pressure when you stand up, which increases fall risk. Rare case reports have linked trazodone to serious heart rhythm abnormalities, so it requires caution in people with existing heart conditions.
Because trazodone increases serotonin, combining it with other serotonin-boosting medications (SSRIs, SNRIs, certain migraine drugs, or MAO inhibitors) raises the risk of serotonin syndrome, a potentially dangerous condition involving agitation, rapid heart rate, high body temperature, and muscle rigidity.